Autres langues Cipla Limited

Actions

CIPLA

INE059A01026

Produits pharmaceutiques

Temps Différé NSE India S.E. 08:00:28 22/09/2026			Varia. 5j.	Varia. 1 janv.
1 366,50 ^INR	-1,41 %		+1,14 %	-9,59 %

03/09	L'indien Cipla et le chinois Qilu s'associent pour le lancement aux États-Unis d'un biosimilaire du Keytruda de Merck	RE
25/08	Inde : le site de Cipla à Pithampur reçoit sept observations de la FDA américaine	MT

Autres langues

04/09	Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda in the US
04/09	Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda(R) (Pembrolizumab) in the US
03/09	India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
25/08	Cipla's Pithampur, India Unit Gets 7 Observations From US FDA
14/08	Patent Disputes Over AI-Assisted Product Features In Consumer Apps
14/08	Cipla Announces Appointment of Runa Akhtar to Marketing Head, Cipla Urology
11/08	Global drugmakers invest billions to boost US presence
06/08	South African Patent Ruling In Favour Of Astellas Pharma
28/07	Cipla Limited Receives U.S. Fda Approval for Generic Advair Diskus
23/07	Cipla Redesignates Global CFO to New Internal Role; Names New CFO
23/07	Cipla Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
23/07	Cipla Limited Announces Cessation of Sanjay Joseph as Senior Managerial Personnel, Effective July 24, 2026
23/07	Cipla Limited Announces Global Chief Financial Officer Changes
23/07	Cipla Limited Announces Executive Changes
23/07	India's Cipla posts another profit decline, names insider Dinesh Jain CFO
22/07	Trump will Generika-Produktion mit massiven Zöllen in die USA zwingen
07/07	India finds Adani's Mumbai airport shops sold nicotine pouches in breach of law
16/06	Cipla Limited Appoints Shivam Puri as Chief Executive Officer of Its One India Business, Effective July 1, 2026
15/06	Global drugmakers invest billions to boost US presence
12/06	India raises price cap on cancer drugs to tackle shortage
11/06	Cipla's Goa, India Facility Receives VAI Status from US FDA
09/06	Indian cancer patients battle shortage of key drugs as platinum costs surge
22/05	India's Sun Pharma posts profit beat on specialty drug demand, shares slide on cost pressures
14/05	Cipla Limited announces Annual dividend, payable on July 25, 2026
13/05	Cipla Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026